Perspective · 29 Jul 2025
Short communicationPublished 29 Sep 2025
Fixed-dose Combinations: Better Outcomes, Lower Costs
Subjects
Pharmaceutical SciencesSimilar by topic
Review article · 1 Jun 2023
Quality by Design (QbD) Approach for Formulation Development and Evaluation of Fixed-Dose Combination Tablets: A Comprehensive Review
Research article · 31 Mar 2023
Bioequivalence and Pharmacokinetics of a Fixed-Dose Combination of Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate in Healthy Thai Volunteers
Research article · 20 Aug 2021
An Open-label, Randomized, Single-dose, Crossover Study in Healthy Adult Volunteers to Evaluate Pharmacokinetic Interactions and Tolerability of a Fixed-dose Combination with Rosuvastatin and Ezetimibe
Mini review · 2020
Effect of Anti-Retroviral Fixed-Dose Combination Tenofovir, Lamivudine, And Evafirenz on Lipid Profile in HIV/AIDS Patients
More from this journal
The newest in Pharmacoeconomics: Open Access.
Opinion · 1 Dec 2025
Drug Repurposing: Economic Gains, Faster Pathways, Rare Diseases
Short communication · 1 Dec 2025
Preventive Drugs for Older Adults: Health and Economic Benefits
Brief report · 29 Nov 2025
Value Assessment Of High-cost Specialty Drugs
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmacoeconomics: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chinedu Okorie”

